Inventor · disambiguated record
Kathleen Danenberg
Also filed as: DANENBERG KATHLEEN · DANENBERG KATHLEEN D
29 granted patents·14 pending applications·1,110 citations·filing 1999–2024
97Inventor score
Files withRESPONSE GENETICS INC14UNIV SOUTHERN CALIFORNIA8LIQUID GENOMICS INC4NANTOMICS LLC4DANENBERG KATHLEEN D3
Top patents by PatentIndex Score
43 records- 0196US6602670B2Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2001·Granted Aug 5, 2003·103 cites·14 claims
- 0296US6248535B1Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 1999·Granted Jun 19, 2001·238 cites·32 claims
- 0395US6582919B2Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival ratesRESPONSE GENETICS INC·Filed 2001·Granted Jun 24, 2003·123 cites·28 claims
- 0495US6331393B1Process for high-throughput DNA methylation analysisUNIV SOUTHERN CALIFORNIA·Filed 1999·Granted Dec 18, 2001·379 cites·26 claims
- 0593US6610488B2Isolation of RNA, DNA and proteins from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 2001·Granted Aug 26, 2003·29 cites·22 claims
- 0693US6428963B2Isolation of RNA from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 2001·Granted Aug 6, 2002·32 cites·26 claims
- 0791US7112404B2Process for high throughput DNA methylation analysisEPIGENOMICS AG·Filed 2001·Granted Sep 26, 2006·42 cites·43 claims
- 0890US8323890B2Process for high-throughput DNA methylation analysisLAIRD PETER W·Filed 2009·Granted Dec 4, 2012·14 cites·19 claims
- 0990US7553627B2Process for high throughput DNA methylation analysisUNIV SOUTHERN CALIFORNIA USC S·Filed 2006·Granted Jun 30, 2009·28 cites·19 claims
- 1089US7132238B2Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2003·Granted Nov 7, 2006·23 cites·4 claims
- 1189US7049059B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2001·Granted May 23, 2006·25 cites·4 claims
- 1288US7732144B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2009·Granted Jun 8, 2010·4 cites·9 claims
- 1388US6613518B2Quantitative measurement of gene expression based on isolation of RNA from formalin-fixed paraffin-embedded tissue specimensUNIV SOURTHERN CALIFORNIA·Filed 2001·Granted Sep 2, 2003·18 cites·6 claims
- 1487US6518416B1Method of determining a chemotherapeutic regimen based on ERCC1 expressionRESPONSE GENETICS INC·Filed 2001·Granted Feb 11, 2003·15 cites·3 claims
- 1586US6573052B2Method of determining a chemotherapeutic regimen based on ERCCI expressionRESPONSE GENETICS INC·Filed 2001·Granted Jun 3, 2003·13 cites·5 claims
- 1684US7919280B2Method for isolation of DNA, RNA and proteins from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 2007·Granted Apr 5, 2011·3 cites·6 claims
- 1783US2024229022A1DNA stabilization of RNANANTOMICS LLC·Filed 2024·Application pending·0 cites
- 1880US7960147B2Quantitative measurement of gene expression based on isolation of RNA from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 2003·Granted Jun 14, 2011·4 cites·22 claims
- 1979US7560543B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionRESPONSE GENETICS INC·Filed 2006·Granted Jul 14, 2009·2 cites·4 claims
- 2075US6956111B2Method of determining dihydropyrimidine dehydrogenase gene expressionRESPONSE GENETICS INC·Filed 2001·Granted Oct 18, 2005·2 cites·6 claims
- 2174US6905821B2Method of determining Dihydropyrimidine dehydrogenase gene expressionRESPONSE GENETICS INC·Filed 2001·Granted Jun 14, 2005·2 cites·15 claims
- 2274US6686155B2Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expressionRESPONSE GENETICS INC·Filed 2001·Granted Feb 3, 2004·5 cites·13 claims
- 2372US11981893B2DNA stabilization of RNANantomics·Filed 2021·Granted May 14, 2024·0 cites·12 claims
- 2470US2024011102A1Use of circulating cell-free rna for diagnosis and/or monitoring cancerLIQUID GENOMICS INC·Filed 2023·Application pending·0 cites
- 2569US8026062B2Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumorsRESPONSE GENETICS INC·Filed 2007·Granted Sep 27, 2011·0 cites·7 claims
- 2668US7138507B2Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expressionRESPONSE GENETICS INC·Filed 2003·Granted Nov 21, 2006·2 cites·3 claims
- 2767US11168323B2DNA stabilization of RNALIQUID GENOMICS INC·Filed 2018·Granted Nov 9, 2021·0 cites·6 claims
- 2866US7005278B2Method of determining dihydropyrimidine dehydrogenase gene expressionDANENBERG KATHLEEN D·Filed 2001·Granted Feb 28, 2006·4 cites·14 claims
- 2964US2004091910A1Isolation of RNA, DNA and proteins from formalin-fixed paraffin-embedded tissue specimensUNIV SOUTHERN CALIFORNIA·Filed 2003·Application pending·0 cites
- 3063US7998707B2Quantitative measurement of gene expression from fixed paraffin embedded tissueUNIV SOUTHERN CALIFORNIA·Filed 2006·Granted Aug 16, 2011·0 cites·28 claims
- 3159US2002142328A1Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumorsFiled 2001·Application pending·0 cites
- 3258US2009092979A1Methods for isolating long fragment rna from fixed samplesRESPONSE GENETICS INC·Filed 2008·Application pending·0 cites
- 3358US2012040346A1Method of Determining Chemotherapy of Metastatic Tumor by Assaying DPD Gene Expression in Primary TumorsDANENBERG KATHLEEN D·Filed 2011·Application pending·0 cites
- 3456US11773447B2Use of circulating cell-free RNA for diagnosis and/or monitoring cancerLIQUID GENOMICS INC·Filed 2015·Granted Oct 3, 2023·0 cites·8 claims
- 3555US2014222443A1Molecular profiling for cancerDANENBERG KATHLEEN·Filed 2012·Application pending·0 cites
- 3654US2005074775A1Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi expressionFiled 2003·Application pending·0 cites
- 3753US2004170983A1Methods of determining a chemotherapuetic regimin based on loss of heterozygosity at the thymidylate synthase locusFiled 2003·Application pending·0 cites
- 3851US8586311B2Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressionDANENBERG KATHLEEN D·Filed 2010·Granted Nov 19, 2013·0 cites·16 claims
- 3950US2020165685A1Circulating rna for detection, prediction, and monitoring of cancerNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 4050US2020248267A1TUMOR VS. MATCHED NORMAL cfRNANANTOMICS LLC·Filed 2018·Application pending·0 cites
- 4149US2020102618A1LIQUID BIOPSY FOR cfRNANANTOMICS LLC·Filed 2018·Application pending·0 cites
- 4245US2020377955A1USE OF CELL-FREE CIRCULATING RNA (cfRNA) EXPRESSION OF PD-L1 AND ERCC1 IN PLASMA TO MONITOR RESPONSE TO THERAPY IN NSCLCLIQUID GENOMICS INC·Filed 2018·Application pending·0 cites
- 4344US2003211530A1Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival ratesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathleen Danenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →